SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-013585
Filing Date
2023-04-20
Accepted
2023-04-20 09:30:20
Documents
16
Period of Report
2023-04-20
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K gern-20230420.htm   iXBRL 8-K 58451
2 EX-99.1 gern-ex99_1.htm EX-99 5963
3 GRAPHIC img50521483_0.jpg GRAPHIC 60272
4 GRAPHIC img50521483_1.jpg GRAPHIC 179961
5 GRAPHIC img50521483_2.jpg GRAPHIC 131809
  Complete submission text file 0000950170-23-013585.txt   755568

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT gern-20230420_pre.xml EX-101.PRE 26218
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT gern-20230420.xsd EX-101.SCH 2561
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT gern-20230420_lab.xml EX-101.LAB 32471
10 EXTRACTED XBRL INSTANCE DOCUMENT gern-20230420_htm.xml XML 4700
Mailing Address 919 EAST HILLSDALE BOULEVARD SUITE 250 FOSTER CITY CA 94404
Business Address 919 EAST HILLSDALE BOULEVARD SUITE 250 FOSTER CITY CA 94404 6504737700
GERON CORP (Filer) CIK: 0000886744 (see all company filings)

IRS No.: 752287752 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-20859 | Film No.: 23831636
SIC: 2834 Pharmaceutical Preparations